Carl W. Ehmann
Directeur/Membre du Conseil chez MUSC Foundation for Research Development
Profil
Carl W.
Ehmann is currently the Director at MUSC Foundation for Research Development and the Treasurer & Director at Guadalupe Center, Inc. Previously, he worked as a Director at Barrier Therapeutics, Inc. from 2004 to 2008, Director-Clinical Research & Dermatology at Hoffman-LaRoche F & Co. AG, VP-Pharmaceutical Research & Development at Bristol Myers Squibb Co., and Executive VP, Head-Global Research & Development at Johnson & Johnson.
He received his undergraduate and doctorate degrees from State University of New York at Buffalo.
Postes actifs de Carl W. Ehmann
| Sociétés | Poste | Début |
|---|---|---|
| MUSC Foundation for Research Development | Directeur/Membre du Conseil | - |
Guadalupe Center, Inc.
 Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Directeur/Membre du Conseil | - |
Anciens postes connus de Carl W. Ehmann
| Sociétés | Poste | Fin |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Directeur/Membre du Conseil | 04/08/2008 |
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | - |
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | - |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Directeur Technique/Scientifique/R&D | - |
Formation de Carl W. Ehmann
| State University of New York at Buffalo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 4 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
| MUSC Foundation for Research Development | |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Guadalupe Center, Inc.
Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Health Services |
